1
Track
Continuous capture of scientific output (ROR, ORCID, General Study, FCT/ERC). Minimum 200 papers/year.
For universities, research centers and TTOs
Turn every publication into a traceable opportunity — connected to market demand.
Science to Impact™ tracks, translates, prioritizes and connects your institution's scientific output to companies looking for exactly that. A continuous technology-transfer pipeline — not one-off analyses.
Science to Impact™
From paper to opportunity, in four steps.
2
Transform
Each validated paper becomes a structured brief (TRL/CRL, applications, adopters, funders). 1 paper = 1 brief.
3
Prioritize
A management dashboard identifies research with real market potential and generates a one-page pitch.
4
Connect
Companies submit challenges → the institution's research surfaces automatically as the solution. Pitch ready for immediate outreach.
Intelligent dashboard for decision-makers
-
Track and visualize every publication, every lab, in real time.
-
Prioritize what matters for real-world application — maturity, readiness to scale and market potential, side by side.
-
Decide based on data: what to patent, license or fund next, with ROI in mind.
Executive Snapshot · University Research Intelligence
Patents (priority)
18
Active licenses
6
Industry projects
9
Policy mentions
12
Opportunity
3 peers doubled “Hydrogen” research in 12 months — pipeline gap +92%
Extract · In production
The National Platform for Health Research Applications.
We applied our methodology to more than 1,000 projects funded by the Brazilian Ministry of Health. Every study became a market-language brief — navigable by public managers, healthcare professionals and policymakers. It's the same engine partner universities run on, live in production today.
364+
studies translated
227
funded projects
1,000+
studies in pipeline
Themes in production
- Primary Care
- Infectious Diseases
- Health Surveillance
- Public Health
- Policy-making
- Clinical Research
Every brief delivers objective, method, key findings, practical applications, target audiences, research stage and societal contribution — ready for decision.
Methodology validated with R$500k of public funding, developed in partnership with UNESP and Recogna Lab. Today's investor funds scale, not development. Concrete proof the engine works at large scale, with public governance and real impact on health policy.
Brazilian Ministry of HealthSUSFiocruzUNESPRecogna LabBill & Melinda Gates Foundation
Standardized brief
1 paper = 1 brief. 22 comparable fields.
From unreadable paper to deal-ready asset. Briefs in market language, comparable to one another, filterable by TRL, CRL, field and adoption potential.
- Objective and problem solved
- Method and study design
- Main applicable finding
- Stage (TRL) and validation context
- Commercial readiness (CRL)
- Practical applications
- Actionable recommendations
- Beneficiaries and adopters
- Investment to reach scale
- Strategic partnerships mapped
Research Brief · EasyTelling
New low-cost method for monitoring bone-marrow transplant drugs in public hospitals
2025 Primary Research Applicable SUS
- Objective
- Validate a fast, precise and affordable laboratory method to measure busulfan blood concentration in pediatric patients.
- Gap it solves
- Busulfan, used in bone-marrow transplants, requires precise dosing. Current methods are costly and complex (mass spectrometry), limiting use in public hospitals.
- Benefit delivered
- Low-cost method, validated under ANVISA regulations, ready for adoption across Brazil's public hospital network.
TRL
6
CRL
4
Your university running as a continuous impact pipeline.
Book a diagnostic and see how your scientific output becomes transfer opportunities.